
Samyukta Mullangi
@samyuktamd
Medical oncologist @TNOncology, Medical director of oncology @ThymeCares | I tweet about oncology, tech innovation, delivery system reform
ID: 284825195
20-04-2011 01:30:17
1,1K Tweet
897 Followers
654 Following


4th year #vandymed student Mason Alford presenting our work on price transparency for common cancer screening services. Excited to continue this important work going forward as he starts residency in July at Vanderbilt GME! Vanderbilt Hem / Onc Vanderbilt University Samyukta Mullangi #ASCO24


1/8 How can patient assistance programs be manipulated to financially harm cancer patients? What are copay accumulator programs and how are they being utilized to shift cost-sharing from plans to patients? Samyukta Mullangi and I aim to answer these q’s and more doi.org/10.1002/cncr.3…




"The government is a significant stakeholder in the healthcare industry, and writ large. Although health care has not been a central issue in the 2024 presidential campaign, the election’s outcome has the potential to affect a wide range of health policies." - Samyukta Mullangi and


This article is harmful for the public. I hope many of us push back against its premise and narrative Community oncologists are often excellent, and they are critical to our collective mission to care for patients with cancer. Without them, our system would collapse Robin Zon, MD, FACP, FASCO

Excited to share our JAMA Oncology paper on CMS’s new PIN codes for illness navigation! These codes aim to improve access to lifesaving care for patients with complex conditions. Our piece examines the promises and pitfalls ahead. Samyukta Mullangi Qasim Hussaini, MD bit.ly/4gbgBuE